130 related articles for article (PubMed ID: 16525490)
61. Taming of the shrew--overcoming extramedullary blast crisis in the era of the new tyrosine kinase inhibitors.
Raanani P
Acta Haematol; 2013; 130(2):108-10. PubMed ID: 23548690
[No Abstract] [Full Text] [Related]
62. Autologous stem cell collection and autograft for patients with chronic myeloid leukemia in the era of ABL kinase inhibitors: back to the bench.
Hui CH; Hughes TP
Leuk Lymphoma; 2006 Sep; 47(9):1721-3. PubMed ID: 17064975
[No Abstract] [Full Text] [Related]
63. Dasatinib may not suppress the GVL effect of donor lymphocyte infusions for CML.
Garland P; Dazzi F; Marin D
Bone Marrow Transplant; 2010 Feb; 45(2):395-6. PubMed ID: 19561650
[No Abstract] [Full Text] [Related]
64. Peripheral blood stem cell autografts in CML.
Hoyle C; Goldman J
Leuk Lymphoma; 1993; 11 Suppl 1():271-5. PubMed ID: 7504545
[TBL] [Abstract][Full Text] [Related]
65. Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied.
Fischer T; Neubauer A; Mohm J; Huhn D; Busemann C; Link H; Arseniev L; Büssing B; Novotny J; Ganser A; Duyster J; Bunjes D; Westermeier T; Flohr T; Desprès D; Gamm H; Decker J; Derigs G; Aulitzky W; Huber C
Ann Hematol; 1998; 77(1-2):21-6. PubMed ID: 9760148
[TBL] [Abstract][Full Text] [Related]
66. Successful treatment of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation with bortezomib.
Cao L; Koh LP; Linn YC
Leuk Lymphoma; 2018 Oct; 59(10):2500-2502. PubMed ID: 29345206
[No Abstract] [Full Text] [Related]
67. Autologous peripheral blood stem cell transplantation for chronic myelocytic leukaemia, using unmanipulated grafts.
Pigneux A; Mahon FX; Reiffers J
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):193-8. PubMed ID: 11000992
[TBL] [Abstract][Full Text] [Related]
68. Different clonal dynamics of chronic myeloid leukaemia between bone marrow and the central nervous system.
Ogawa M; Yokoyama K; Hirano M; Jimbo K; Ochi K; Kawamata T; Ohno N; Shimizu E; Yokoyama N; Yamaguchi R; Imoto S; Uchimaru K; Takahashi N; Miyano S; Imai Y; Tojo A
Br J Haematol; 2018 Dec; 183(5):842-845. PubMed ID: 29265350
[No Abstract] [Full Text] [Related]
69. All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand.
Kruger P; Cooney J; Nivison-Smith I; Dodds A; Bardy P; Ma D; Szer J; Durrant S
Bone Marrow Transplant; 2016 Oct; 51(10):1400-1403. PubMed ID: 27214080
[No Abstract] [Full Text] [Related]
70. Acute lymphocytic blast crisis as an ocular manifestation of chronic granulocytic leukemia.
Lakosha H; Simpson R; Patterson B; Minden M; Payne D; Lipton JH
Can J Ophthalmol; 2000 Oct; 35(6):336-9. PubMed ID: 11091917
[No Abstract] [Full Text] [Related]
71. Sudden blast crisis in chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Hiwase DK; Hughes TP
Leuk Lymphoma; 2012 Jul; 53(7):1251-2. PubMed ID: 22475357
[No Abstract] [Full Text] [Related]
72. Treatment of chronic myeloid leukaemia.
Allan NC; Shepherd PC
Baillieres Clin Haematol; 1987 Dec; 1(4):1031-54. PubMed ID: 2461756
[No Abstract] [Full Text] [Related]
73. Disseminated aspergillosis after mobilization with intensive chemotherapy prior to autologous stem-cell transplant in chronic myeloid leukemia.
Ferrer F; Moraleda JM; Toldos MC; Heras I; Vicente V
Am J Hematol; 1997 Feb; 54(2):170-1. PubMed ID: 9034295
[No Abstract] [Full Text] [Related]
74. Re-mobilization of hematopoietic progenitors for further autografting after prior myelo-ablative high-dose chemotherapy and autologous hematopoietic stem cell transplantation;
Kosmas C; Kranidioti E; Kosma A; Karakosta M; Miltiadous C; Grivas A; Athanasopoulos A; Lianos E
Leuk Lymphoma; 2019 Jul; 60(7):1819-1822. PubMed ID: 30618317
[No Abstract] [Full Text] [Related]
75. [Recombinant alpha-interferon (reaferon) in the treatment of patients with chronic myeloleukemia].
Khoroshko ND; Savchenko VG; Kholopova EI; Kotel'nikov VM; Zakharova AV; Semenova EA; Marchenko VI
Ter Arkh; 1990; 62(7):41-7. PubMed ID: 2251664
[TBL] [Abstract][Full Text] [Related]
76. A spontaneous remission of lymphoid blast crisis in chronic myelogenous leukaemia following blood transfusion and infection.
Lefrere F; Hermine O; Radford-Weiss I; Veil A; Picard F; Dreyfus F; Flandrin G; Varet B
Br J Haematol; 1994 Nov; 88(3):621-2. PubMed ID: 7819077
[TBL] [Abstract][Full Text] [Related]
77. Mobilization/transplantation of Ph1-negative blood progenitor cells in chronic myelogenous leukaemia.
Carella AM; Podestà M; Lerma E; Dejana A; Prencipe E; Vassallo F; Crescenti C; Soracco M; Benvenuto F; Chimirri F; Carlier P; Florio G; Valbonesi M; Frassoni F
Ann Oncol; 1996; 7 Suppl 2():19-22. PubMed ID: 8805945
[No Abstract] [Full Text] [Related]
78. Autologous peripheral blood haematopoietic stem cell transplantation for chronic myelogenous leukaemia.
Carella AM; Cavalierè M; Lerma E; Corsetti MT
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):209-17. PubMed ID: 11000994
[TBL] [Abstract][Full Text] [Related]
79. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases.
Reiffers J; Trouette R; Marit G; Montastruc M; Fabères C; Cony-Makhoul P; David B; Bourdeau MJ; Bilhou-Nabera C; Lacombe F
Br J Haematol; 1991 Mar; 77(3):339-45. PubMed ID: 1672819
[TBL] [Abstract][Full Text] [Related]
80. Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia.
Simonsson B; Oberg G; Björeman M; Björkholm M; Gahrton G; Hast R; Killander A; Turesson I; Udén AM; Vikrot O
Leuk Lymphoma; 1992; 7 Suppl():55-7. PubMed ID: 1283548
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
